| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |